← All stocks

BIODESIX INC

BDSX Net buying
CIK 0001439725 #3725 in the set updated 17 Sep 2026
Bought (120 mo)
$66.67M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$724.67K
$0.00 on a plan · $2.29K straight out of an exercise
Sold at will
$722.39K
129 of 134 sales
Net
+$65.94M
+$65.94M against sales at will

By person

15 insiders · 249 transactions
1.8×

Scott Hutton holds only 1.8 times base salary in stock. $1.19M of shares against $643.40K in salary for 2025.

Salary from the company's own proxy. The shares are what Scott Hutton last reported holding, valued at $24.47, the price Common Stock was last bought or sold at on the open market here, on 12 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
SCHULER JACK W
10% owner
$41.93M (42)
+$41.93M
6,869,540
$168.07M
Kennedy Lawrence T. Jr
Director
$12.64M (5)
+$12.64M
10,411,024
$254.72M
Strobeck Matthew
Director
$7.27M (13)
+$7.27M
5,277,349
$129.12M
PATIENCE JOHN
Director
$4.04M (10)
+$4.04M
6,940,904
$169.82M
MASSARANY HANY
Director
$315.86K (3)
+$315.86K
363,499
$8.89M
Hutton Scott
President & CEO
$118.37K (2)
$424.07K (26)
−$305.69K
48,767
$1.19M
Kayyem Jon Faiz
Director
$200.00K (1)
+$200.00K
357,537
$8.75M
Watts Charles M
Director
$111.13K (3)
+$111.13K
421,705
$10.32M
Cowie Robin Harper
CFO, Sec'y & Treasurer
$24.51K (2)
$118.77K (26)
−$94.26K
16,231
$397.11K
O'Kane Kieran
Chief Commercial Officer
$73.09K (26)
−$73.09K
9,819
$240.23K
Pestano Gary Anthony
Chief Development Officer
$69.08K (26)
−$69.08K
10,359
$253.44K
Siurek Ryan H
Chief Accounting Officer
$16.30K (7)
−$16.30K
40,268
$985.20K
+198.1%
Vazquez Chris
Chief Accounting Officer
$13.61K (19)
−$13.61K
1,586
$38.80K
Georgantas Robert William III
Chief Scientific Officer
$11.79K (2)
$9.76K (4)
+$2.03K
38,214
$934.95K
+888.5%
Franchi Jean M.
Director
108,140
$2.65M

No percentages here. This company's share count has moved by a factor of 18.4 over the window, from 7,955,685 to 146,633,352 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 317
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 5
Sales at will 129
Transactions with no price 0
Shares from compensation/vesting 35,717,846
Sales filed before the plan box existed 29
History held since 3 Nov 2020